{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:57:05Z","timestamp":1771563425895,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200-2012-53581"],"award-info":[{"award-number":["200-2012-53581"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.082","type":"journal-article","created":{"date-parts":[[2017,4,9]],"date-time":"2017-04-09T12:01:27Z","timestamp":1491739287000},"page":"2668-2675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines"],"prefix":"10.1016","volume":"35","author":[{"given":"G. Thomas","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ned","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pat","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.082_b0005","first-page":"27","article-title":"Nasal flu vaccine approved","volume":"37","author":"Meadows","year":"2003","journal-title":"FDA Consum"},{"key":"10.1016\/j.vaccine.2017.03.082_b0010","unstructured":"MedImmune. Flumist Quadrivalent [Draft package insert]. Gaithersburg, MD: MedImmune; 2015."},{"key":"10.1016\/j.vaccine.2017.03.082_b0015","first-page":"1217","article-title":"Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2\u20134 years and other FluMist changes for the 2007\u201308 influenza season","volume":"56","author":"Centers for disease control and prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.082_b0020","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","volume":"57","author":"Fiore","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2017.03.082_b0025","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2012\u201313 Influenza Season","volume":"61","author":"Grohskopf","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.082_b0030","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2014\u201315 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.082_b0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.15585\/mmwr.mm6430a3","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015\u201316 Influenza Season","volume":"64","author":"Grohskopf","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.03.082_b0040","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.inf.0000109392.96411.4f","article-title":"Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents","volume":"23","author":"Bergen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.082_b0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.082_b0050","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1542\/peds.2004-2258","article-title":"Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial","volume":"116","author":"Piedra","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.03.082_b0055","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2013.01.055","article-title":"A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24\u201359 months of age","volume":"31","author":"Toback","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.03.082_b0060","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1016\/j.vaccine.2012.02.039","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.082_b0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/INF.0b013e3181660c2e","article-title":"Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial","volume":"27","author":"Gaglani","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.082_b0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.082_b0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.082_b0080","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2011.04.113","article-title":"A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years","volume":"29","author":"Tennis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.082_b0085","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1016\/j.vaccine.2012.07.031","article-title":"A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009\u20132010 season","volume":"30","author":"Tennis","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.082_b0090","first-page":"CD000364","article-title":"Vaccines for preventing influenza in people with asthma","author":"Cates","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2017.03.082_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep: Morbidity and mortality weekly report Recommendations and reports\/Centers for Disease Control."},{"key":"10.1016\/j.vaccine.2017.03.082_b0100","unstructured":"Public Health Agency of Canada. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2016\u20132017; 2016."},{"key":"10.1016\/j.vaccine.2017.03.082_b0105","unstructured":"Public Health England. The National Childhood Flu Immunisation Programme 2016\/17 Information for healthcare practitioners; 2016."},{"key":"10.1016\/j.vaccine.2017.03.082_b0110","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ppul.20476","article-title":"Modifications to HEDIS and CSTE algorithms improve case recognition of pediatric asthma","volume":"41","author":"Wakefield","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.vaccine.2017.03.082_b0115","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/aje\/kwp173","article-title":"Influenza vaccination and mortality: differentiating vaccine effects from bias","volume":"170","author":"Fireman","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.03.082_b0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell's palsy in children: a case-centered analysis","volume":"175","author":"Rowhani-Rahbar","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.03.082_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cid\/ciw224","article-title":"Case centered analysis of Optic Neuritis following vaccines","volume":"63","author":"Baxter","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.082_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0194599816639043","article-title":"Sudden-onset sensorineural hearing loss after immunization: a case-centered analysis","volume":"155","author":"Baxter","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2017.03.082_b0135","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"Klein","year":"2015","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17304346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:37:53Z","timestamp":1655692673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17304346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":27,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17304346"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}